PURE Bioscience, Inc. (OTCMKTS:PURE – Get Free Report) shares crossed above its two hundred day moving average during trading on Wednesday . The stock has a two hundred day moving average of $0.07 and traded as high as $0.10. PURE Bioscience shares last traded at $0.10, with a volume of 17,461 shares traded.
PURE Bioscience Stock Performance
The stock has a market capitalization of $10.63 million, a P/E ratio of -2.38 and a beta of 0.35. The stock’s fifty day simple moving average is $0.07 and its two-hundred day simple moving average is $0.07.
PURE Bioscience (OTCMKTS:PURE – Get Free Report) last posted its quarterly earnings data on Monday, March 17th. The company reported ($0.01) earnings per share for the quarter. The firm had revenue of $0.39 million for the quarter.
About PURE Bioscience
PURE Bioscience, Inc develops and commercializes antimicrobial products that provide solutions to the health and environmental challenges of pathogen and hygienic control in the United States and internationally. The company manufactures and distributes silver dihydrogen citrate (SDC), a non-toxic antimicrobial agent, which offers residual protection, as well as formulates with other compounds.
Featured Stories
- Five stocks we like better than PURE Bioscience
- What Are Dividend Champions? How to Invest in the Champions
- Is Consumer Discretionary a Dead End? These 3 Stocks Say No
- Which Wall Street Analysts are the Most Accurate?
- Why a Trump-Musk Feud Could Mean Big Wins for AST SpaceMobile
- The Risks of Owning Bonds
- Nintendo Stock Near Highs—Will the Switch 2 Keep the Rally Alive?
Receive News & Ratings for PURE Bioscience Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for PURE Bioscience and related companies with MarketBeat.com's FREE daily email newsletter.
